| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-09-22 10:50 Tx date 2026-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$283,200
+20,000 vol $14.16 each |
1,009,953 | |
| Filed 2026-09-22 10:49 Tx date 2026-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,600
+20,000 vol $1.18 each |
989,953 | |
| Filed 2026-09-22 10:46 Tx date 2026-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-283,200
-20,000 vol $14.16 each |
969,953 | |
| Filed 2026-09-22 10:44 Tx date 2026-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-283,200
-20,000 vol $14.16 each |
877,304 | |
| Older filings | ||||||
| Filed 2026-09-02 10:37 Tx date 2026-09-02 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-56,880
-4,000 vol $14.22 each |
0 | |
| Filed 2026-09-02 10:35 Tx date 2026-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-950,109.30
-66,815 vol $14.22 each |
4,000 | |
| Filed 2026-09-02 10:33 Tx date 2026-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$1,006,989
+70,815 vol $14.22 each |
70,815 | |
| Filed 2026-06-25 14:43 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-18,740.19
-1,149 vol $16.31 each |
2,689 | |
| Filed 2026-06-25 14:42 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$40,475
+2,500 vol $16.19 each |
3,838 | |
| Filed 2026-06-25 14:41 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-40,475
-2,500 vol $16.19 each |
5,000 | |
| Filed 2026-06-25 14:29 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$-18,740.19
-1,149 vol $16.31 each |
2,689 | |
| Filed 2026-06-25 14:17 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$40,475
+2,500 vol $16.19 each |
3,838 | |
| Filed 2026-06-25 14:15 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-40,475
-2,500 vol $16.19 each |
5,000 | |
| Filed 2026-06-25 14:08 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$40,475
+2,500 vol $16.19 each |
989,953 | |
| Filed 2026-06-25 14:07 Tx date 2026-06-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-40,475
-2,500 vol $16.19 each |
33,013 | |
| Filed 2026-06-25 13:41 Tx date 2026-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
$40,850
+2,500 vol $16.34 each |
35,513 | |
| Filed 2026-06-25 13:39 Tx date 2026-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
$40,850
+2,500 vol $16.34 each |
7,500 | |
| Filed 2026-06-25 13:34 Tx date 2026-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
$40,850
+2,500 vol $16.34 each |
7,500 | |
| Filed 2026-06-25 13:31 Tx date 2026-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
$40,824
+2,500 vol $16.33 each |
||
| Filed 2026-06-25 13:28 Tx date 2026-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$81,649
+5,000 vol $16.33 each |
40,000 | |